Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure. A Double-Blind, Placebo-Controlled, Randomized Study

Journal of the American College of Cardiology

Volumn 54, Issue 10, 2009, Pages 919-927

  Caminiti, Giuseppe ^a   Volterrani, Maurizio ^a   Iellamo, Ferdinando ^a,b   Marazzi, Giuseppe ^a   Massaro, Rosalba ^a   Miceli, Marco ^a   Mammi, Caterina ^a   Piepoli, Massimo ^c   Fini, Massimo ^a   Rosano, Giuseppe M C ^a  

^a Cardiovascular Research Unit   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c GUGLIELMO DA SALICETO HOSPITAL   (Italy)

Author keywords

baroreflex sensitivity; congestive heart failure; exercise capacity; glucose metabolism; testosterone

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CARBON DIOXIDE; CHOLESTEROL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LONG ACTING DRUG; OXYGEN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL;

AGED; ANDROGEN THERAPY; ARTERIAL PRESSURE; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG FATALITY; EXERCISE TOLERANCE; FOLLOW UP; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGONADISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; KIDNEY FUNCTION; LIVER FUNCTION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATIENT COMPLIANCE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SIDE EFFECT; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALKING;

AGED; BAROREFLEX; BLOOD GLUCOSE; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; INJECTIONS, INTRAMUSCULAR; INSULIN RESISTANCE; LEG; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; TESTOSTERONE; TESTOSTERONE CONGENERS; VENTRICULAR FUNCTION, LEFT;

EID: 68949172537     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.078     Document Type: Article

References (50)

1. Levy D., Kenchaian S., Larson M.G., et al. Long-term trend in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
2. Coats A.J., Clark A.L., Piepoli M., Volterrani M., and Poole-Wilson P.A. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 72 (1994) S36-S39
3. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
4. Moriyama Y., Yasue H., Yoshimura M., et al. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J Clin Endocrinol Metab 85 (2000) 1834-1840
5. Kontoleon P.E., Anastasiou-Nana M.I., Papapetrou P.D., et al. Hormonal profile in patients with congestive heart failure. Int J Cardiol 87 (2003) 179-183
6. Pugh P.J., Jones R.D., West J.N., Jones T.H., and Channer K.S. Testosterone treatment for men with chronic heart failure. Heart 90 (2004) 446-447
7. Jankowska E.A., Biel B., Majda J., et al. Anabolic deficiency in men with chronic heart failure prevalence and detrimental impact on survival. Circulation 114 (2006) 1829-1837
8. Pugh P.J., Jones T.H., and Channer K.S. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J 24 (2003) 909-915
9. Malkin C.J., Pugh P.J., West J.N., Van Beek E.J.R., Jones T.H., and Channer K.S. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 27 (2006) 57-64
10. Malkin C.J., Jones T.H., and Channer K.S. The effect of testosterone on insulin sensitivity in men with heart failure. Eur J Heart Fail 9 (2007) 44-50
11. Pina I.L., Apstein C.S., Balady G.J., et al. Exercise and heart failure. A statement from the American Heart Association Committee on Exercise, Rehabilitation and Prevention. Circulation 107 (2003) 1210-1225
12. Swedberg K., Cleland J., Dargie H., et al. Guidelines on the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
13. El-Mas M.M., Afify E.A., Mohy El-Din M.M., Omar A.G., and Sharabi F.M. Testosterone facilitates the baroreceptor control of reflex bradycardia: role of cardiac sympathetic and parasympathetic components. J Cardiovasc Pharmacol 38 (2001) 754-763
14. El-Mas M.M., Afify E.A., Omar A.G., and Sharabi F.M. Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Therap 301 (2002) 346-354
15. Ward G.R., and Abdel-Rahman A.A. Orchiectomy or androgen receptor blockade attenuates baroreflex-mediated bradycardia in conscious rats. BMC Pharmacol 6 (2006) 2
16. Mortara A., La Rovere M.T., Pinna G.D., et al. Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 96 (1997) 3450-3458
17. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society Echocardiography Committee on Standards, Subcommittee on Quantitation of two-dimensional echocardiograms. Am Soc Echocardiogr 2 (1989) 358-367
18. Iellamo F., Legramante J.M., Raimondi G., et al. Effects of isokinetic, isotonic and isometric submaximal exercise on heart rate and blood pressure. Eur J Appl Physiol 75 (1997) 89-96
19. Iellamo F., Massaro M., Raimondi G., Peruzzi P., and Legramante J.M. Role of muscular factors in cardiorespiratory responses to static exercise: contribution of reflex mechanisms. J Appl Physiol 86 (1999) 174-180
20. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Bertinieri G., Di Rienzo M., Cavallazzi A., Ferrari A.V., Pedotti A., and Mancia G. Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol 254 (1988) H377-H383
23. Legramante J.M., Massaro M., Raimondi G., and Iellamo F. Positive and negative feedback mechanisms in the neural regulation of the cardiovascular function in healthy and spinal cord-injured humans. Circulation 103 (2001) 1250-1255
24. Iellamo F., Galante A., Legramante J.M., et al. Altered autonomic cardiac regulation in individuals with Down syndrome. Am J Physiol Heart Circ Physiol 289 (2005) H2387-H2391
25. Parlow J., Viale J.P., Annat A., Hughson R., and Quintin L. Spontaneous cardiac baroreflex in humans: comparison with drug-induced responses. Hypertension 25 (1995) 1058-1068
26. Parati G., Di Rienzo M., and Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18 (2000) 7-19
27. Morales F.J., Martinez A., Mendez M., et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J 138 (1999) 291-298
28. Lewis M.E., Newall C., Townend J.N., Hill S.L., and Bonser R.S. Incremental shuttle walk test in the assessment of patients for heart transplantation. Heart 86 (2001) 183-187
29. Morales F.J., Montemayor T., and Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure. Int J Cardiol 76 (2000) 101-105
30. Fleg J.L., Pina I.L., Balady G.J., et al. Assessment of functional capacity in clinical and research applications. An advisory from the Committee on Exercise, Rehabilitation and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 102 (2000) 1591-1597
31. Francis D., Shamin W., Davies L.C., et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2 slope and peak VO2. Eur Heart J 21 (2000) 154-161
32. Arena R., Myers J., and Abella J. Development of a ventilatory classification system in patients with heart failure. Circulation 115 (2007) 2410-2417
33. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 29 (1997) 1585-1590
34. Hambrecht R., Fiehn E., Yu J., et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29 (1997) 1067-1073
35. Piepoli M., Clark A.L., Volterrani M., Adamopoulos S., Sleight P., and Coats A.J.S. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training. Circulation 93 (1996) 940-949
36. Piepoli M.F., Kaczmarek A., Francis D.P., et al. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation 114 (2006) 126-134
37. Iellamo F., Sala-Mercado J.A., Ichinose M., et al. Spontaneous baroreflex control of heart rate during exercise and muscle metaboreflex activation in heart failure. Am J Physiol Heart Circ Physiol 293 (2007) H1929-H1936
38. Ponikowski P.P., Chua T.P., Francis D.P., Capucci A., Coats A.J.S., and Piepoli M.F. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 104 (2001) 2324-2330
39. Piepoli M.F., Scott A.C., Capucci A., and Coats A.J. Skeletal muscle training in chronic heart failure. Acta Physiol Scand 171 (2001) 295-303
40. Czesla M., Mehlhorn G., Fritzsche D., and Asmussen G. Cardiomyoplasty-improvement of muscle fibre type transformation by anabolic steroid. J Mol Cell Cardiol 29 (1997) 2989-2996
41. Ustünel I., Akkoyunlu G., and Demir R. The effect of testosterone on gastrocnemius muscle fibres in growing and adult male and female rats: a histochemical, morphometric and ultrastructural study. Anat Histol Embryol 32 (2003) 70-79
42. Coviello A.D., Kaplan B., Lakshman K.M., Chen T., Singh A.B., and Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93 (2008) 914-919
43. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30 (1997) 527-532
44. Ingelsson E., Sundstrom J., Amlov J., Zethelius B., and Lind L. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
45. Lee C.H., Kuo S.W., Hung Y.J., et al. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res 31 (2005) 139-148
46. Kapoor D., Goodwin E., Channer K.S., and Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154 (2006) 899-906
47. Malkin C.J., Jones T.H., and Channer K.S. The effect of testosterone on insulin sensitivity in men with heart failure. Eur J Heart Fail 9 (2007) 44-50
48. Eckberg D.L., and Sleight P. Congestive heart failure. In: Eckberg D.L., and Sleight P. (Eds). Human Baroreflexes in Health and Disease (1992), Clarendon Press, Oxford 399-436
49. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294 (1990) 76-95
50. Harle L., Basaria S., and Dobs A.S. Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother 6 (2005) 1751-1759